FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

1992011000001107: Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1898301000001119 Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1898321000001114 Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
24897301000001112 Oxybutynin 2.5mg tablets (Kent Pharmaceuticals Ltd) 84 tablet 4 x 21 tablets (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
24897401000001116 Oxybutynin 2.5mg tablets (Kent Pharmaceuticals Ltd) 84 tablet 4 x 21 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38019201000001112 Oxybutynin 2.5mg tablets (Kent Pharmaceuticals Ltd) 84 tablet 12 x 7 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Is a Oxybutynin 2.5mg tablets 84 tablet true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Is pack of Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Has active ingredient Oxybutynin hydrochloride false Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Has active ingredient Oxybutynin false Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Has AMP Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Has specific active ingredient Oxybutynin hydrochloride true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 12 x 7 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start